Accessibility Menu
electroCore logo

electroCore(NASDAQ) ECOR

Current Price$6.23
Market Cap$55.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-98%
5 Year-59%
1 Year-17%
1 Month-18%
electroCore last closing stock price
MetricPriceDate
Last closeUSD 6.192026-07-24
electroCore stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.27%USD 5.882026-07-17
1 month-18.23%USD 7.572026-06-24
3 month+0.24%USD 6.182026-04-24
Year to date+38.02%USD 4.492025-12-31
1 year-17.19%USD 7.482025-07-24
3 year+41.32%USD 4.382023-07-25
5 year-59.1%USD 15.132021-07-23
Since inception-97.86%USD 297.752018-06-22

electroCore Financials at a Glance

Market Cap

$55.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$34.90M

Net Income (TTM)

-$15.38M

EPS (TTM)

-$1.81

P/E Ratio

-3.41

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Price

$6.23

Volume

1,146

Open

$6.62

Previous Close

$6.23

Daily Range

$6.02 - $6.62

52-Week Range

$4.16 - $10.50

Estimated Earnings Date

Aug 5, 2026

ECOR News

Foolcom-Featured.png

electroCore (ECOR) Q2 Revenue Jumps 20%

Motley Fool Markets TeamAug 6, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About electroCore

electroCore makes handheld devices that help manage pain from migraines and headaches. Its products are used by adults needing non-drug pain relief. The company also offers wellness devices for general health and performance.

Gadgets That Zap: Products and Services

  • Prescription Devices (75.2% of revenue): gammaCore and Quell, used for migraine, cluster headache, and fibromyalgia pain relief in adults.
  • General Wellness: Truvaga, a consumer device for stress and wellbeing, sold online and in stores.
  • Military/Performance: TAC-STIM, a non-prescription device for human performance, sold to military and professionals.
  • International Sales: Devices sold to international customers, including the U.K. National Health Service for headache treatment.
  • Other/Legacy: Replacement parts and in-licensed products for existing customers.

Growth Spurts and Bold Moves

  • Acquired NeuroMetrix in May 2025, adding Quell devices for fibromyalgia and pain.
  • Launched gammaCore Emerald, a next-generation device, in April 2025.
  • Expanded U.S. government sales through a new agreement with Lovell Government Services initiated in 2023.
  • Increased headquarters space in Rockaway, New Jersey, with a lease extension to 2034.
  • Entered the U.K. market, with NHS sales making up 4.4% of 2025 revenue.

What Makes electroCore Stand Out

The company focuses on non-invasive, portable devices for pain and wellness. It holds over 215 patents and works closely with U.S. government healthcare systems. Its products combine medical technology with digital health features, like app integration.

Five Things You Need to Know

  • Net sales were $32.0 million in 2025, up 27% from 2024.
  • Gross margin reached 87% in 2025, up from 85% in 2024.
  • U.S. Department of Veterans Affairs accounted for 71.2% of 2025 revenue.
  • Operating loss was $13.2 million in 2025, compared to $12.2 million in 2024.
  • Cash, equivalents, and securities totaled $11.6 million at year-end 2025.

Bottom Line

electroCore has grown by expanding its product range and government partnerships. Its focus on non-invasive pain relief and wellness devices shapes its evolving business model.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

83

CEO

Daniel S. Goldberger

Website

www.electrocore.com

Headquarters

Rockaway, NJ 07866, US

ECOR Financials

Key Financial Metrics (TTM)

Gross Margin

87.25%

Operating Margin

-41.97%

Net Income Margin

-44.08%

Return on Equity

836.32%

Return on Capital

-170.95%

Return on Assets

-99.35%

Earnings Yield

-29.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$55.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

9.02M

Volume

1.15K

Avg. Volume

111.89K

Financials (TTM)

Gross Profit

$30.45M

Operating Income

-$14.65M

EBITDA

-$13.27M

Operating Cash Flow

-$6.84M

Capital Expenditure

-$31.00K

Free Cash Flow

-$6.87M

Cash & ST Invst.

$8.83M

Total Debt

$9.49M

electroCore Performance Analysis

electroCore annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 8,592,00057.6%
20232023-12-31USD 16,030,00086.6%
20242024-12-31USD 25,182,00057.1%
20252025-12-31USD 32,032,00027.2%
electroCore sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-309.9%
Q32025-09-3017.7%
Q42025-12-316.4%
Q12026-03-313.7%
electroCore annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -4.697.4%
20232023-12-31USD -3.42-27.1%
20242024-12-31USD -1.59-53.5%
20252025-12-31USD -1.653.7%
electroCore sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-306.4%
Q32025-09-309.1%
Q42025-12-315.0%
Q12026-03-31-55.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$9.58M

+42.6%

Gross Profit

$8.36M

+46.6%

Gross Margin

87.27%

N/A

Market Cap

$55.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$672.39K

N/A

Employees

83

N/A

Net Income

-$5.27M

-36.7%

EBITDA

-$5.23M

-40.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$8.83M

+13.8%

Total Debt

$9.49M

+126.7%

Accounts Receivable

$872.00K

-40.2%

Inventory

$1.98M

+14.1%

Long Term Debt

$8.86M

+131.9%

Short Term Debt

$628.00K

+72.5%

Return on Assets

-99.35%

N/A

Return on Invested Capital

-4.62%

N/A

Free Cash Flow

-$3.01M

+31.5%

Operating Cash Flow

-$3.01M

+30.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PYPDPolyPid Ltd.
$3.90-8.02%
YI111, Inc.
$4.00+5.26%
RNXTRenovoRx, Inc.
$0.87+1.26%
BTAIBioXcel Therapeutics, Inc.
$0.85-2.62%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
TAT&T
$24.13+0.05%
AALAmerican Airlines Group
$14.48+0.07%

Questions About ECOR

What is the current price of electroCore?

electroCore is trading at $6.23 per share.

What is the 52-week range for electroCore?

Over the past 52 weeks, electroCore has traded between $4.16 and $10.50.

How much debt does electroCore have?

As of the most recent reporting period, electroCore reported total debt of $9.49M.

How much cash does electroCore have on hand?

electroCore reported $4.85M in cash and cash equivalents in its most recent financial results.

What is electroCore’s dividend yield?

electroCore does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services